---
title: "OrthoPediatrics Corp. (KIDS.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/KIDS.US.md"
symbol: "KIDS.US"
name: "OrthoPediatrics Corp."
industry: "Health Care Supplies"
datetime: "2026-04-16T21:26:21.809Z"
locales:
  - [en](https://longbridge.com/en/quote/KIDS.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KIDS.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KIDS.US.md)
---

# OrthoPediatrics Corp. (KIDS.US)

## Company Overview

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | US Market |
| Website | [www.orthopediatrics.com](https://www.orthopediatrics.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-04-16T04:30:17.000Z

**Overall: C (0.45)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 21 / 45 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 15.45% |  |
| Net Profit YoY | -4.83% |  |
| P/B Ratio | 1.30 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 451226347.95 |  |
| Revenue | 236348000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -11.31% | D |
| Profit Margin | -16.78% | D |
| Gross Margin | 73.05% | A |
| Revenue YoY | 15.45% | B |
| Net Profit YoY | -4.83% | C |
| Total Assets YoY | 7.49% | B |
| Net Assets YoY | -2.25% | D |
| Cash Flow Margin | 12.24% | C |
| OCF YoY | 15.45% | B |
| Turnover | 0.48 | C |
| Gearing Ratio | 31.86% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - OrthoPediatrics Corp.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "15.45%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-4.83%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.30",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "451226347.95",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "236348000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-11.31%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-16.78%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "73.05%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "15.45%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-4.83%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "7.49%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "-2.25%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "12.24%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "15.45%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.48",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "31.86%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -11.38 | 38/45 | - | - | - |
| PB | 1.30 | 15/45 | 1.51 | 1.33 | 1.22 |
| PS (TTM) | 1.91 | 19/45 | 2.49 | 2.05 | 1.88 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Essilor (ESLOY.US) | B | B | C | B | B | B |
| 02 | HOYA Corporation (HOCPY.US) | A | B | B | A | B | B |
| 03 | Medline (MDLN.US) | C | B | B | C | B | B |
| 04 | Align (ALGN.US) | B | C | B | B | C | B |
| 05 | Lantheus (LNTH.US) | A | C | B | C | C | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-15T04:00:00.000Z

Total Analysts: **9**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 5 | 56% |
| Overweight | 3 | 33% |
| Hold | 1 | 11% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 16.53 |
| Highest Target | 34.00 |
| Lowest Target | 20.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/KIDS.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/KIDS.US/norm.md)
- [Related News](https://longbridge.com/en/quote/KIDS.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/KIDS.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**